Equities analysts forecast that Encompass Health Corp (NYSE:EHC) will report $1.09 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Encompass Health’s earnings, with the lowest sales estimate coming in at $1.08 billion and the highest estimate coming in at $1.13 billion. Encompass Health reported sales of $1.02 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 6.9%. The firm is expected to report its next earnings results on Monday, February 25th.
On average, analysts expect that Encompass Health will report full year sales of $4.27 billion for the current year, with estimates ranging from $4.26 billion to $4.31 billion. For the next financial year, analysts expect that the company will post sales of $4.53 billion, with estimates ranging from $4.49 billion to $4.56 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Encompass Health.
Encompass Health (NYSE:EHC) last posted its earnings results on Monday, October 29th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.79 by $0.12. Encompass Health had a net margin of 7.73% and a return on equity of 23.51%. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion.
Separately, UBS Group assumed coverage on shares of Encompass Health in a research report on Thursday, November 15th. They issued a “buy” rating and a $86.00 price target for the company. One equities research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $74.86.
Encompass Health stock traded down $1.48 during trading hours on Wednesday, hitting $73.01. The company had a trading volume of 733,460 shares, compared to its average volume of 540,156. The stock has a market cap of $7.44 billion, a price-to-earnings ratio of 26.45, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52. The company has a debt-to-equity ratio of 1.58, a current ratio of 1.05 and a quick ratio of 1.05. Encompass Health has a 1 year low of $48.54 and a 1 year high of $82.46.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 15th. Shareholders of record on Wednesday, January 2nd will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend is Monday, December 31st. Encompass Health’s dividend payout ratio is presently 39.13%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Article: What are the benefits of a balanced fund?
Get a free copy of the Zacks research report on Encompass Health (EHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.